Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 2
Submit an article Journal homepage
1,838
Views
4
CrossRef citations to date
0
Altmetric
Vaccine Safety

Safety of BCG vaccination and revaccination in healthcare workers

Paola Villanuevaa Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia;b Infection and Immunity, Murdoch Children’s Research Institute, Parkville, VIC, Australia;c Infectious Diseases, Royal Children’s Hospital Melbourne, Parkville, VIC, Australia;d Department of General Medicine, Royal Children’s Hospital Melbourne, Parkville, VIC, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6504-2979View further author information
ORCID Icon,
Nigel W. Crawforda Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia;b Infection and Immunity, Murdoch Children’s Research Institute, Parkville, VIC, Australia;d Department of General Medicine, Royal Children’s Hospital Melbourne, Parkville, VIC, Australia;e Immunisation Service, Royal Children’s Hospital Melbourne, Parkville, VIC, AustraliaORCID Iconhttps://orcid.org/0000-0003-1851-5080View further author information
ORCID Icon,
Mariana Garcia Crodaf School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, BrazilORCID Iconhttps://orcid.org/0000-0003-1436-9717View further author information
ORCID Icon,
Simone Collopyg Department of Pediatrics, Universidade Estadual do Rio de Janeiro, Rio de Janeiro, BrazilORCID Iconhttps://orcid.org/0000-0001-9346-4194View further author information
ORCID Icon,
Bruno Araújo Jardimh Carlos Borborema Clinical Research Institute, Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, BrazilORCID Iconhttps://orcid.org/0000-0003-3465-7556View further author information
ORCID Icon,
Tyane de Almeida Pinto Jardimh Carlos Borborema Clinical Research Institute, Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, BrazilORCID Iconhttps://orcid.org/0000-0002-2104-2897View further author information
ORCID Icon,
Helen Marshalli The University of Adelaide and the Women’s and Children’s Health Network, Adelaide, SA, AustraliaORCID Iconhttps://orcid.org/0000-0003-2521-5166View further author information
ORCID Icon,
Cristina Prat-Aymerichj Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands;k Institut d’Investigació Germans Trias i Pujol, Departament de Genètica i Microbiologia, CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Universitat Autònoma de Barcelona, Badalona, SpainORCID Iconhttps://orcid.org/0000-0001-6974-9165View further author information
ORCID Icon,
Alice Sawkal Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, SA, AustraliaORCID Iconhttps://orcid.org/0000-0003-0944-3185View further author information
ORCID Icon,
Ketaki Sharmam National Centre for Immunisation Research and Surveillance, Westmead, NSW, Australia;n The Children’s Hospital at Westmead, Westmead, NSW, AustraliaORCID Iconhttps://orcid.org/0000-0002-4875-1909View further author information
ORCID Icon,
Darren Troemanj Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, NetherlandsORCID Iconhttps://orcid.org/0000-0002-8418-1480View further author information
ORCID Icon,
Ushma Wadiao Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, WA, AustraliaORCID Iconhttps://orcid.org/0000-0002-8097-5072View further author information
ORCID Icon,
Adilia Warrisp Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter, UK;q Department of Infectious Diseases, Great Ormond Street Hospital, London, UKORCID Iconhttps://orcid.org/0000-0002-2181-3604View further author information
ORCID Icon,
Nicholas Woodm National Centre for Immunisation Research and Surveillance, Westmead, NSW, Australia;n The Children’s Hospital at Westmead, Westmead, NSW, Australia;r The Children’s Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, AustraliaView further author information
,
Nicole L. Messinaa Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia;b Infection and Immunity, Murdoch Children’s Research Institute, Parkville, VIC, AustraliaORCID Iconhttps://orcid.org/0000-0001-8404-4462View further author information
ORCID Icon,
Nigel Curtisa Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia;b Infection and Immunity, Murdoch Children’s Research Institute, Parkville, VIC, Australia;c Infectious Diseases, Royal Children’s Hospital Melbourne, Parkville, VIC, AustraliaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3446-4594View further author information
ORCID Icon &
Laure F. Pitteta Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia;b Infection and Immunity, Murdoch Children’s Research Institute, Parkville, VIC, Australia;c Infectious Diseases, Royal Children’s Hospital Melbourne, Parkville, VIC, Australia;s Infectious Diseases Unit, Department of Paediatrics, Gynaecology and Obstetrics, Faculty of Medicine, University of Geneva, University Hospitals of Geneva, Geneva, SwitzerlandORCID Iconhttps://orcid.org/0000-0002-2395-4574View further author information
ORCID Icon show all
Article: 2239088 | Received 15 May 2023, Accepted 16 Jul 2023, Published online: 08 Aug 2023

References

  • Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG world atlas: a database of global BCG vaccination policies and practices. PLoS Med. 2011;8(3):e1001012. doi:10.1371/journal.pmed.1001012.
  • Nemes E, Geldenhuys H, Rozot V, Rutkowski KT, Ratangee F, Bilek N, Mabwe S, Makhethe L, Erasmus M, Toefy A, et al. Prevention of M. tuberculosis infection with H4: IC31 vaccine or BCG revaccination. N Engl J Med. 2018;379(2):138–11. doi:10.1056/NEJMoa1714021.
  • Katelaris AL, Jackson C, Southern J, Gupta RK, Drobniewski F, Lalvani A, Lipman M, Mangtani P, Abubakar I. Effectiveness of BCG vaccination against mycobacterium tuberculosis infection in adults: A Cross-sectional Analysis of a UK-Based cohort. J Infect Dis. 2020;221(1):146–55. doi:10.1093/infdis/jiz430.
  • Biering-Sørensen S, Aaby P, Lund N, Monteiro I, Jensen KJ, Eriksen HB, Schaltz-Buchholzer F, Jørgensen ASP, Rodrigues A, Fisker AB, et al. Early BCG-Denmark and neonatal mortality among infants weighing <2500 g: a randomized controlled trial. Clin Infect Dis. 2017;65(7):1183–90. doi:10.1093/cid/cix525.
  • Arts RJW, Moorlag S, Novakovic B, Li Y, Wang SY, Oosting M, Kumar V, Xavier RJ, Wijmenga C, Joosten LAB, et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe. 2018;23(1):89–100.e5. doi:10.1016/j.chom.2017.12.010.
  • Curtis N, Sparrow A, Ghebreyesus TA, Netea MG. Considering BCG vaccination to reduce the impact of COVID-19. Lancet. 2020;395(10236):1545–6. doi:10.1016/S0140-6736(20)31025-4.
  • Zirimenya L, Nkurunungi G, Nassuuna J, Natukunda A, Mutebe A, Oduru G, Kabami G, Akurut H, Onen C, Namutebi M, et al. Impact of BCG revaccination on the response to unrelated vaccines in a Ugandan adolescent birth cohort: randomised controlled trial protocol C for the ‘POPulation differences in VACcine responses’ (POPVAC) programme. BMJ Open. 2021;11(2):e040430. doi:10.1136/bmjopen-2020-040430.
  • Angelidou A, Pittet LF, Faustman D, Curtis N, Levy O. BCG vaccine’s off-target effects on allergic, inflammatory, and autoimmune diseases: worth another shot? J Allergy Clin Immunol. 2022;149(1):51–4. doi:10.1016/j.jaci.2021.09.034.
  • Pittet LF, Messina NL, Orsini F, Moore CL, Abruzzo V, Barry S, Bonnici R, Bonten M, Campbell J, Croda J, et al. Randomized trial of BCG vaccine to protect against Covid-19 in health care workers. N Engl J Med. 2023;388(17):1582–96. doi:10.1056/NEJMoa2212616.
  • Villanueva P, Wadia U, Crawford N, Messina NL, Kollmann TR, Lucas M, Manning L, Ricmond P, Pittet LF, Curtis N. Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy. NPJ Vaccines. 2022;7(1):6. doi:10.1038/s41541-021-00421-5.
  • Pittet LF, Messina NL, Gardiner K, Orsini F, Abruzzo V, Bannister S, Bonten M, Campbell JL, Croda J, Dalcolmo M, et al. BCG vaccination to reduce the impact of COVID-19 in healthcare workers: protocol for a randomised controlled trial (BRACE trial). BMJ Open. 2021;11(10):e052101. doi:10.1136/bmjopen-2021-052101.
  • Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81. doi:10.1016/j.jbi.2008.08.010.
  • US Food and Drug Administration. Guidance for Industry: toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials. 2007 [accessed 2021 May 16]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/toxicity-grading-scale-healthy-adult-and-adolescent-volunteers-enrolled-preventive-vaccine-clinical.
  • U.S. Department of Health and Human Services NIoH, National Institute of Allergy and Infectious Diseases, Division of AIDS. Division of AIDS (DAIDS) table for grading the severity of adult and pediatric adverse events, corrected version 2.1. 2017.
  • Australian Technical Advisory Group on Immunisation (ATAGI). Australian immunisation handbook: BCG vaccination procedures. 2018 [accessed 2022 July 20]. https://immunisationhandbook.health.gov.au/.
  • Ustvedt HJ. Local reaction in BCG vaccination. Bull World Health Organ. 1950;2:441–68.
  • Schaltz-Buchholzer F, Berendsen M, Roth A, Jensen KJ, Bjerregaard-Andersen M, Kjær Sørensen M, Monteiro I, Aaby P, Stabell Benn C. BCG skin reactions by 2 months of age are associated with better survival in infancy: a prospective observational study from Guinea-Bissau. BMJ Glob Health. 2020;5(9):e002993. doi:10.1136/bmjgh-2020-002993.
  • Funch KM, Thysen SM, Rodrigues A, Martins CL, Aaby P, Benn CS, Fisker AB. Determinants of BCG scarification among children in rural Guinea-Bissau: a prospective cohort study. Hum Vaccin Immunother. 2018;14(10):2434–42. doi:10.1080/21645515.2017.1421879.
  • Birk NM, Nissen TN, Ladekarl M, Zingmark V, Kjærgaard J, Jensen TM, Jensen SK, Thøstesen LM, Kofoed PE, Stensballe LG, et al. The association between Bacillus Calmette-Guérin vaccination (1331 SSI) skin reaction and subsequent scar development in infants. BMC Infect Dis. 2017;17(1):540. doi:10.1186/s12879-017-2641-0.
  • Rani SH, Vijayalakshmi V, Sunil K, Lakshmi KA, Suman LG, Murthy KJ. Cell mediated immunity in children with scar-failure following BCG vaccination. Indian Pediatr. 1998;35:123–7.
  • Santiago EM, Lawson E, Gillenwater K, Kalangi S, Lescano AG, Du Quella G, Cummings K, Cabrera L, Torres C, Gilman RH. A prospective study of bacillus Calmette-Guérin scar formation and tuberculin skin test reactivity in infants in Lima, Peru. Pediatrics. 2003;112(4):e298. doi:10.1542/peds.112.4.e298.
  • Jensen TM, Jensen SK, Birk NM, Rieckmann A, Hoffmann T, Benn CS, Jeppesen DL, Pryds O, Nissen TN. Determinants of Bacille Calmette-Guérin scarification in Danish children. Heliyon. 2021;7(1):e05757. doi:10.1016/j.heliyon.2020.e05757.
  • Villanueva P, Crawford NW, Croda MG, Collopy S, Jardim BA, de Almeida Pinto Jardim T, Manning L, Lucas M, Marshall H, Prat-Aymerich C, et al. Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination. Heliyon. 2023;9(4):e15241. doi:10.1016/j.heliyon.2023.e15241.
  • EMC Electronic medicines compendium. BCG vaccine AJV summary of product characteristics. 2019 [accessed 2021 Mar 16]. https://www.medicines.org.uk/emc/product/9890#gref.
  • McGuire R. Melbourne vaccine education centre: injection site reactions. 2022.
  • UC San Diego Health. Understanding post-injection inflammation. 2022 [accessed 2022 July 21]. https://myhealth.ucsd.edu/Search/3,90744.
  • Hervé C, Laupèze B, Del Giudice G, Didierlaurent AM, Tavares Da Silva F. The how’s and what’s of vaccine reactogenicity. NPJ Vaccines. 2019;4:39. doi:10.1038/s41541-019-0132-6.
  • Gorse GJ, Falsey AR, Johnson CM, Morrison D, Fried DL, Ervin JE, Greenberg DP, Ozol-Godfrey A, Landolfi V, Tsang PH. Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18–64 years of age. Vaccine. 2013;31(50):6034–40. doi:10.1016/j.vaccine.2013.09.012.
  • Roozen GVT, Prins MLM, van Binnendijk R, Hartog G, Kuiper VP, Prins C, Janse JJ, Kruithof AC, Feltkamp MCW, Kuijer M, et al. Tolerability, safety and immunogenicity of intradermal delivery of a fractional dose mRNA-1273 SARS-CoV-2 vaccine in healthy adults as a dose sparing strategy. medRxiv. 2021; 2021.2007.2027.21261116. doi:10.2139/ssrn.3892129.
  • Roth AE, Benn CS, Ravn H, Rodrigues A, Lisse IM, Yazdanbakhsh M, Whittle H, Aaby P. Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau. Bmj. 2010;340:c671. doi:10.1136/bmj.c671.
  • Mathur ML, Raman S. Potential utility of BCG test in excluding tuberculosis in adults. Respir Med. 2003;97(5):528–32. doi:10.1053/rmed.2003.1478.
  • Myint TT, Yin Y, Yi MM, Aye HH. BCG test reaction in previously BCG vaccinated children. Ann Trop Paediatr. 1985;5(1):29–31. doi:10.1080/02724936.1985.11748355.
  • Singla M, Sahai V, Sodhi S, Gupta RP. BCG skin reaction in Mantoux-negative healthy children. BMC Infect Dis. 2005;5(1). doi:10.1186/1471-2334-5-19.
  • Villanueva P, Pittet LF, Nourse C, Curtis N. What is the significance of an accelerated BCG reaction in children? Arch Dis Child. 2022;107(5):507–12. doi:10.1136/archdischild-2022-323853.
  • Upton CM, van Wijk RC, Mockeliunas L, Simonsson USH, McHarry K, van den Hoogen G, Muller C, von Delft A, van der Westhuizen HM, van Crevel R, et al. Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: a double-blind, randomised, controlled, phase 3 trial. EClinicalMedicine. 2022;48:101414. doi:10.1016/j.eclinm.2022.101414.
  • Dos Anjos LRB, da Costa AC, Cardoso A, Guimarães RA, Rodrigues RL, Ribeiro KM, Borges KCM, Carvalho ACO, Dias CIS, Rezende AO, et al. Efficacy and safety of BCG revaccination with M. bovis BCG Moscow to prevent COVID-19 infection in health care workers: a randomized phase II clinical trial. Front Immunol. 2022;13:841868. doi:10.3389/fimmu.2022.841868.
  • Jeena PM, Chhagan MK, Topley J, Coovadia HM. Safety of the intradermal Copenhagen 1331 BCG vaccine in neonates in Durban, South Africa. Bull World Health Organ. 2001;79:337–43.
  • Dommergues MA, de La Rocque F, Guy C, Lécuyer A, Jacquet A, Guérin N, Fagot JP, Boucherat M, d’Athis P, Cohen R, et al. Local and regional adverse reactions to BCG-SSI® vaccination: a 12-month cohort follow-up study. Vaccine. 2009;27(50):6967–73. doi:10.1016/j.vaccine.2009.09.073.
  • Turnbull FM, McIntyre PB, Achat HM, Wang H, Stapledon R, Gold M, Burgess MA. National study of adverse reactions after vaccination with bacille Calmette-Guerin. Clin Infect Dis. 2002;34:447–53. doi:10.1086/338462.
  • Grange JM. Complications of bacille Calmette-Guérin (BCG) vaccination and immunotherapy and their management. Commun Dis Public Health. 1998;1:84–8.
  • Biering-Sørensen S, Jensen KJ, Aamand SH, Blok B, Andersen A, Monteiro I, Netea MG, Aaby P, Benn CS, Hasløv KR. Variation of growth in the production of the BCG vaccine and the association with the immune response. An observational study within a randomised trial. Vaccine. 2015;33(17):2056–65. doi:10.1016/j.vaccine.2015.02.056.
  • Villanueva P, Pittet LF, Curtis N. Management of Bacille Calmette-Guérin lymphadenitis and abscess in immunocompetent children: a systematic review. Pediatr Infect Dis J. 2021;40(11):1037–45. doi:10.1097/INF.0000000000003237.
  • Kim J, Lee K, Kim JH, Kim SJ, Lee SY, Lee HJ, Cho KS, Kwon YJ, Lee BC, Jo SM, et al. The incidence rate of lymphadenitis after Bacille Calmette-Guérin (BCG) vaccination. Pediatr Infect Vaccine. 2016;23(1):54–61. doi:10.14776/piv.2016.23.1.54.
  • Lotte A, Wasz-Hockert O, Poisson N, Dumitrescu N, Verron M, Couvet E. BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res. 1984;21:107–93.
  • World Health Organization. BCG vaccines: WHO position paper – February 2018. Wkly Epidemiol Rec. 2018;93(8):73–96.
  • Milstien JB, Gibson JJ. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull World Health Organ. 1990;68:93–108.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.